Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EndiCor was a medical device company that developed innovative catheter-based technologies for the treatment of vascular diseases. The company's flagship product, the X-Sizer Catheter System, was a mechanical thrombectomy device designed to remove blood clots from coronary and peripheral arteries. This technology was particularly effective in treating patients with high-thrombus-burden lesions, reducing the risk of distal embolization during interventional procedures. In July 2002, EndiCor was acquired by Medtronic for approximately $77 million in cash plus potential milestone payments. The acquisition allowed Medtronic to integrate specialized thrombectomy solutions into its broader vascular intervention portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EndiCor.